Sensitisation of cancer cells to radiotherapy by serine and glycine starvation

Br J Cancer. 2022 Nov;127(10):1773-1786. doi: 10.1038/s41416-022-01965-6. Epub 2022 Sep 17.

Abstract

Background: Cellular metabolism is an integral component of cellular adaptation to stress, playing a pivotal role in the resistance of cancer cells to various treatment modalities, including radiotherapy. In response to radiotherapy, cancer cells engage antioxidant and DNA repair mechanisms which mitigate and remove DNA damage, facilitating cancer cell survival. Given the reliance of these resistance mechanisms on amino acid metabolism, we hypothesised that controlling the exogenous availability of the non-essential amino acids serine and glycine would radiosensitise cancer cells.

Methods: We exposed colorectal, breast and pancreatic cancer cell lines/organoids to radiation in vitro and in vivo in the presence and absence of exogenous serine and glycine. We performed phenotypic assays for DNA damage, cell cycle, ROS levels and cell death, combined with a high-resolution untargeted LCMS metabolomics and RNA-Seq.

Results: Serine and glycine restriction sensitised a range of cancer cell lines, patient-derived organoids and syngeneic mouse tumour models to radiotherapy. Comprehensive metabolomic and transcriptomic analysis of central carbon metabolism revealed that amino acid restriction impacted not only antioxidant response and nucleotide synthesis but had a marked inhibitory effect on the TCA cycle.

Conclusion: Dietary restriction of serine and glycine is a viable radio-sensitisation strategy in cancer.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acids
  • Animals
  • Antioxidants / metabolism
  • Glycine / pharmacology
  • Mice
  • Pancreatic Neoplasms*
  • Serine* / metabolism

Substances

  • Serine
  • Glycine
  • Antioxidants
  • Amino Acids